Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.uan.edu.co/handle/123456789/2667
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.advisorCano Paniagua, Alejandra-
dc.contributor.advisorGaleano Castañeda, Yadira Bernarda-
dc.creatorLondoño David, Laura María-
dc.creatorTorres Rivas, Sara Liz-
dc.date.accessioned2021-03-04T20:26:32Z-
dc.date.available2021-03-04T20:26:32Z-
dc.date.created2020-06-02-
dc.identifier.urihttp://repositorio.uan.edu.co/handle/123456789/2667-
dc.description.abstractNatural antioxidants such as resveratrol and docosahexaenoic acid (DHA) have been studied for their potential properties in different eye conditions, this has led to the identification of the implementation of resveratrol and DHA in the improvement of retinal pigment epithelium storage in adults, light-induced retinal degeneration, attenuation of the inflammatory retinal condition and damage from diabetic retinopathy. The objective of this bibliographic review is to describe the existing evidence of the use of DHA and resveratrol in the management of angiogenesis at the eye level through a bibliographic review, through a review of documents from the last 20 years of scientific societies dedicated to visual health, indexed in the databases, demonstrating the importance and benefits that dha and resveratrol use brings in the management and improvement of eye angiogenesis and its studies on the subject, concluding that they are natural alternatives that contribute to a stoppage or delay in the progression of retinal degenerative diseases, which should be studied more deeply for an expansion of information for greater clinical utility.es_ES
dc.description.tableofcontentsAntioxidantes naturales como el resveratrol y el ácido docosahexaenoico (DHA) han sido estudiados por sus potenciales propiedades en diferentes afecciones oculares, lo cual ha permitido identificar la implementación de resveratrol y DHA en la mejora del almacenamiento del epitelio pigmentario retinal en adultos, la degeneración retiniana inducida por la luz, la atenuación de la condición inflamatoria de la retina y el daño a causa de la retinopatía diabética. El objetivo de esta revisión bibliográfica es Describir la evidencia existente del uso del DHA y resveratrol en el manejo de la angiogénesis a nivel ocular a través de una revisión bibliográfica, mediante una revisión de documentos de los últimos 20 años de sociedades científicas dedicadas a salud visual, indexados en las bases de datos, evidenciando la importancia y beneficios que aporta el uso del DHA y resveratrol en el manejo y mejoría de la angiogénesis ocular y a su vez la poca existencia de estudios sobre el tema, llegando a la conclusión de que son alternativas naturales que contribuyen una detención o retardo en la progresión de enfermedades degenerativas retinianas, que deben ser estudiadas más profundamente para una expansión de la información para mayor utilidad clínicaes_ES
dc.language.isospaes_ES
dc.publisherUniversidad Antonio Nariñoes_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América*
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Estados Unidos de América*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.sourceinstname:Universidad Antonio Nariñoes_ES
dc.sourcereponame:Repositorio Institucional UANes_ES
dc.sourceinstname:Universidad Antonio Nariñoes_ES
dc.sourcereponame:Repositorio Institucional UANes_ES
dc.subjectAcido docosahexaenoico (DHA)es_ES
dc.subjectResveratroles_ES
dc.subjectAngiogénesis oculares_ES
dc.subjectNeovascularizaciónes_ES
dc.subject.ddc617es_ES
dc.titleÁcido docosahexaenoico (DHA) y el resveratrol en el manejo de la angiogénesis a nivel ocular: Revisión bibliográficaes_ES
dc.typebachelorThesises_ES
dc.subject.lemboptometríaes_ES
dc.publisher.programOptometríaes_ES
dc.rights.accesRightsopenAccesses_ES
dc.subject.keywordDocosahexaenoic acid (DHA)es_ES
dc.subject.keywordResveratroles_ES
dc.subject.keywordOcular angiogenesises_ES
dc.subject.keywordNeovascularizationes_ES
dc.type.spaTrabajo de grado (Pregrado y/o Especialización)es_ES
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersiones_ES
dc.source.bibliographicCitationRodríguez Gallo CM, Medina Caballero G, Cabrera Hernández D, Díaz Hernández E. Medicina natural y tradicional. Conocimientos y aplicaciones de enfermería en MINAS-II. Rev Cubana Enferm. 2002;18(3):138–43.es_ES
dc.source.bibliographicCitationAung T, Qu Z, Kortschak R, Adelson D. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int J Mol Sci [Internet]. 2017 Mar 17;18(3):656. Available from: http://www.mdpi.com/1422-0067/18/3/656es_ES
dc.source.bibliographicCitationCheng C, Li Z, Zhao X, Liao C, Quan J, Bode AM, et al. Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases. Eur J Pharmacol [Internet]. 2020 Mar;870:172922. Available from:https://linkinghub.elsevier.com/retrieve/pii/S0014299920300145es_ES
dc.source.bibliographicCitationObulesu M. Natural Products in the Treatment of Alzheimer’s Disease. In: Alzheimer’s Disease Theranostics [Internet]. Elsevier; 2019. p. 19–24. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128164129000045es_ES
dc.source.bibliographicCitationLi J, Long X, Hu J, Bi J, Zhou T, Guo X, et al. Multiple pathways for natural product treatment of Parkinson’s disease: A mini review. Phytomedicine [Internet]. 2019 Jul 1 [cited 2020 Apr 8];60:152–954. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0944711319301230es_ES
dc.source.bibliographicCitationChen D-Q, Hu H-H, Wang Y-N, Feng Y-L, Cao G, Zhao Y-Y. Natural products for the prevention and treatment of kidney disease. Phytomedicine [Internet]. 2018 Nov;50:50–60. Available from: https://linkinghub.elsevier.com/retrieve/pii/S094471131830463Xes_ES
dc.source.bibliographicCitationPourang A, Hendricks AJ, Shi VY. Managing dermatology patients who prefer “all natural” treatments. Clin Dermatol [Internet]. 2019 Oct 27 [cited 2020 Apr 8]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0738081X19302019es_ES
dc.source.bibliographicCitationDembitsky VM, Dzhemileva L, Gloriozova T, D’yakonov V. Natural and synthetic drugs used for the treatment of the dementia. Biochem Biophys Res Commun [Internet]. 2020 Apr 9 [cited 2020 Apr 8];524(3):772–83. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0006291X20302060es_ES
dc.source.bibliographicCitationChu K-O, Pang C-P. Herbal molecules in eye diseases. Taiwan J Ophthalmol [Internet]. 2014 Sep 1 [cited 2020 Apr 8];4(3):103–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2211505614000283es_ES
dc.source.bibliographicCitationDinte E, Vostinaru O, Samoila O, Sevastre B, Bodoki E. Ophthalmic Nanosystems with Antioxidants for the Prevention and Treatment of Eye Diseases. Coatings [Internet]. 2020 Jan 1;10(1):36. Available from: https://www.mdpi.com/2079-6412/10/1/36es_ES
dc.source.bibliographicCitationJohnsen-Soriano S, Genovés JM, Romero B, García-Delpech S, Muriach M, Sancho-Tello M, et al. Estrés oxidativo en la retina de la rata inducido por la administración crónica de etanol: tratamiento con el antioxidante ebselen. Arch Soc Esp Oftalmol [Internet]. 2007 Dec;82(12):757–62. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912007001200008&lng=en&nrm=iso&tlng=enes_ES
dc.source.bibliographicCitationMares JA, Millen AE, Lawler TP, Blomme CK. Diet and Supplements in the Prevention and Treatment of Eye Diseases. In: Nutrition in the Prevention and Treatment of Disease [Internet]. Fourth Edi. Elsevier; 2017. p. 393–434. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128029282000199es_ES
dc.source.bibliographicCitationDoganay S, Firat PG, Cankaya C, Kirimlioglu H. Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn. Burns [Internet]. 2013 Mar;39(2):326–30. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0305417912002367es_ES
dc.source.bibliographicCitationChiang H, Hemmati H. Treatment of Corneal Neovascularization [Internet]. American Academy of Ophthalmology. 2013. p. 35,36. Available from: https://www.aao.org/eyenet/article/treatment-of-corneal-neovascularizationes_ES
dc.source.bibliographicCitationChang J-H, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol [Internet]. 2001 Aug;12(4):242–9. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage& an=00055735-200108000-00002es_ES
dc.source.bibliographicCitationBrantley MA, Sternberg P. Mechanisms of Oxidative Stress in Retinal Injury. In: Retina [Internet]. Fifth Edit. Elsevier; 2013. p. 517–28. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9781455707379000229es_ES
dc.source.bibliographicCitationWorld Health Organisation. World report on vision [Internet]. Vol. 214, World health Organisation. 2019. Available from: https://www.who.int/publications-detail/world-report-on-visiones_ES
dc.source.bibliographicCitationChen Y, Meng J, Li H, Wei H, Bi F, Liu S, et al. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1. Exp Eye Res [Internet]. 2019 Apr;181:356–66. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0014483518302732es_ES
dc.source.bibliographicCitationKubota S, Kurihara T, Ebinuma M, Kubota M, Yuki K, Sasaki M, et al. Resveratrol Prevents Light-Induced Retinal Degeneration via Suppressing Activator Protein-1 Activation. Am J Pathol [Internet]. 2010 Oct;177(4):1725–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002944010602258es_ES
dc.source.bibliographicCitationPasovic L, Eidet JR, Lyberg T, Messelt EB, Aabel P, Utheim TP. Antioxidants Improve the Viability of Stored Adult Retinal Pigment Epithelial-19 Cultures. Ophthalmol Ther [Internet]. 2014 Dec 29;3(1–2):49–61. Available from: http://link.springer.com/10.1007/s40123-014-0024-9es_ES
dc.source.bibliographicCitationVang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, et al. What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol. Vina J, editor. PLoS One [Internet]. 2011 Jun 16;6(6):e19881. Available from: http://dx.plos.org/10.1371/journal.pone.0019881es_ES
dc.source.bibliographicCitationBrâkenhielm E, Cao R, Cao Y. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J [Internet]. 2001 Aug 8;15(10):1798–800. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1096/fj.01-0028fjees_ES
dc.source.bibliographicCitationContín MA, Arietti MM, Benedetto MM, Bussi C, Guido ME. Photoreceptor damage induced by low-intensity light: model of retinal degeneration in mammals. Mol Vis [Internet]. 2013;19:1614–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23901245es_ES
dc.source.bibliographicCitationJaadane I, Villalpando Rodriguez GE, Boulenguez P, Chahory S, Carré S, Savoldelli M, et al. Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo. J Cell Mol Med [Internet]. 2017 Dec;21(12):3453–66. Available from: http://doi.wiley.com/10.1111/jcmm.13255es_ES
dc.source.bibliographicCitationJaadane I, Boulenguez P, Chahory S, Carré S, Savoldelli M, Jonet L, et al. Retinal damage induced by commercial light emitting diodes (LEDs).Free Radic Biol Med [Internet]. 2015 Jul;84:373–84. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0891584915001586es_ES
dc.source.bibliographicCitationDomej W, Oetll K, Renner W. Oxidative stress and free radicals in COPD – implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis [Internet]. 2014 Oct;9:1207. Available from: http://www.dovepress.com/oxidative-stress-and-free-radicals-in-copd- ndash-implications-and-rele-peer-reviewed-article-COPDes_ES
dc.source.bibliographicCitationAbu-Amero K, Kondkar A, Chalam K. Resveratrol and Ophthalmic Diseases. Nutrients [Internet]. 2016 Apr 5;8(4):200. Available from: http://www.mdpi.com/2072-6643/8/4/200es_ES
dc.source.bibliographicCitationWei J, Gronert K. The role of pro-resolving lipid mediators in ocular diseases. Mol Aspects Med [Internet]. 2017 Dec;58:37–43. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0098299717300225es_ES
dc.source.bibliographicCitationHe J, Bazan HEP. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins, Leukot Essent Fat Acids [Internet]. 2010 Apr;82(4–6):319–25. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0952327810000487es_ES
dc.source.bibliographicCitationSuvarna V, Sarkar M, Chaubey P, Murahari M, Sangave PC. Role of Natural Products in Glaucoma Management. In: Handbook of Nutrition, Diet, and the Eye [Internet]. 2nd ed. Elsevier; 2019. p. 221–30. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128152454000132es_ES
dc.source.bibliographicCitationHua J, Guerin KI, Chen J, Michán S, Stahl A, Krah NM, et al. Resveratrol Inhibits Pathologic Retinal Neovascularization in Vldlr −/− Mice. Investig Opthalmology Vis Sci [Internet]. 2011 Apr 25;52(5):2809. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.10-6496es_ES
dc.source.bibliographicCitationLiu Z, Wu Z, Li J, Marmalidou A, Zhang R, Yu M. Protective effect of resveratrol against light-induced retinal degeneration in aged SAMP8 mice. Oncotarget [Internet]. 2017 Sep 12;8(39). Available from: http://www.oncotarget.com/fulltext/19473es_ES
dc.source.bibliographicCitationSouied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, et al. Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration. Ophthalmology [Internet]. 2013 Aug;120(8):1619–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0161642013000079es_ES
dc.source.bibliographicCitationMerle BMJ, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH. Circulating Omega-3 Fatty Acids and Neovascular Age-Related Macular Degeneration. Investig Opthalmology Vis Sci [Internet]. 2014 Mar 28;55(3):2010. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.14-13916es_ES
dc.source.bibliographicCitationRicher S, Ulanski L, Popenko NA, Pratt SG, Hitchmoth D, Chous P, et al. Age-related Macular Degeneration Beyond the Age-related Eye Disease Study II. Adv Ophthalmol Optom [Internet]. 2016 Aug;1(1):335–69. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2452176016300038es_ES
dc.source.bibliographicCitationSaxena S. Antioxidants and Age-related Macular Degeneration. In: Focus on Macular Diseases [Internet]. Jaypee Brothers Medical Publishers (P) Ltd.; 2007. p. 261–261. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128152454000065es_ES
dc.source.bibliographicCitationHellström A, Smith LEH, Dammann O. Retinopathy of prematurity. Lancet [Internet]. 2013 Oct;382(9902):1445–57. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673613601786es_ES
dc.source.bibliographicCitationCai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye [Internet]. 2002 May 28;16(3):242–60. Available from: http://www.nature.com/articles/6700133es_ES
dc.source.bibliographicCitationPerdriel G. Diabetic Retinopathy [Internet]. Duh EJ, editor. Vol. 48, Therapeutique (La Semaine des hopitaux). Totowa, NJ: Humana Press; 2008. 615–617 p. Available from: http://link.springer.com/10.1007/978-1-59745-563-3es_ES
dc.source.bibliographicCitationJin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Investig Ophthalmol Vis Sci [Internet]. 2009 Oct 1;50(10):4743–52. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.08-2462es_ES
dc.source.bibliographicCitationGong Y, Fu Z, Liegl R, Chen J, Hellström A, Smith LEH. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. Am J Clin Nutr [Internet]. 2017 Jul;106(1):16–26. Available from: https://academic.oup.com/ajcn/article/106/1/16-26/4634038es_ES
dc.source.bibliographicCitationUstáriz-gonzález O, Furno-sola F, Quiroz-mercado H. Angiogénesis ocular. Revisión del tema. Rev Mex Oftalmol [Internet]. 2006;80(5):268–71. Available from: https://www.medigraphic.com/pdfs/revmexoft/rmo-2006/rmo065h.pdfes_ES
dc.source.bibliographicCitationSulaiman RS, Basavarajappa HD, Corson TW. Natural product inhibitors of ocular angiogenesis. Exp Eye Res [Internet]. 2014 Dec;129:161–71. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0014483514002668es_ES
dc.source.bibliographicCitationGhasemi Falavarjani K, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye [Internet]. 2013 Jul 31;27(7):787–94. Available from: http://www.nature.com/articles/eye2013107es_ES
dc.source.bibliographicCitationDong A, Xie B, Shen J, Yoshida T, Yokoi K, Hackett SF, et al. Oxidative stress promotes ocular neovascularization. J Cell Physiol [Internet]. 2009 Jun;219(3):544–52. Available from: http://doi.wiley.com/10.1002/jcp.21698es_ES
dc.source.bibliographicCitationBerson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al. Clinical Trial of Lutein in Patients With Retinitis Pigmentosa Receiving Vitamin A. Arch Ophthalmol [Internet]. 2010 Apr 1;128(4):403. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archophthalmol.2010.32es_ES
dc.source.bibliographicCitationSandre PC, de Velasco PC, Serfaty CA. The Impact of Low Omega-3 Fatty Acids Diet on the Development of the Visual System. In: Handbook of Nutrition, Diet, and the Eye [Internet]. 2nd ed. Elsevier; 2019. p.369–95. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128152454000235es_ES
dc.source.bibliographicCitationSerini S, Cassano R, Facchinetti E, Amendola G, Trombino S, Calviello G. Anti-Irritant and Anti-Inflammatory Effects of DHA Encapsulated in Resveratrol-Based Solid Lipid Nanoparticles in Human Keratinocytes. Nutrients [Internet]. 2019 Jun 21;11(6):1400. Available from: https://www.mdpi.com/2072-6643/11/6/1400es_ES
dc.source.bibliographicCitationHuang DD, Shi G, Jiang Y, Yao C, Zhu C. A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications [Internet]. Vol. 125, Biomedicine and Pharmacotherapy. Elsevier; 2020. p.109767. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0753332219353892es_ES
dc.source.bibliographicCitationAhmad I, Hoda M. Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action. Life Sci [Internet]. 2020 Mar;245. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0024320520300977es_ES
dc.source.bibliographicCitationKubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, et al. Prevention of Ocular Inflammation in Endotoxin-Induced Uveitis with Resveratrol by Inhibiting Oxidative Damage and Nuclear Factor–κB Activation. Investig Opthalmology Vis Sci [Internet]. 2009 Jul 1;50(7):3512. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.08-2666es_ES
dc.source.bibliographicCitationChen W, Esselman WJ, Jump DB, Busik J V. Anti-inflammatory Effect of Docosahexaenoic Acid on Cytokine-Induced Adhesion Molecule Expression in Human Retinal Vascular Endothelial Cells. Investig Opthalmology Vis Sci [Internet]. 2005 Nov 1;46(11):4342. Available from: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.05-0601es_ES
dc.source.bibliographicCitationNagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicits dilation of isolated porcine retinal arterioles: Role of nitric oxide and potassium channels. Investig Ophthalmol Vis Sci [Internet]. 2007 Sep 1;48(9):4232–9. Available from:http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.07-0094es_ES
dc.source.bibliographicCitationZhang T-T, Xu J, Wang Y-M, Xue C-H. Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids. Prog Lipid Res [Internet]. 2019 Jul;75:100997. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782719300402es_ES
dc.source.bibliographicCitationYang R-H, Lin J, Hou X-H, Cao R, Yu F, Liu H-Q, et al. Effect of docosahexaenoic acid on hippocampal neurons in high-glucose condition: Involvement of PI3K/AKT/nuclear factor-κB-mediated inflammatory pathways. Neuroscience [Internet]. 2014 Aug;274:218–28. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0306452214004424es_ES
dc.source.bibliographicCitationZarrouk A, Nury T, Samadi M, O’Callaghan Y, Hammami M, O’Brien NM, et al. Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid (DHA; C22:6 n-3). Steroids [Internet]. 2015 Jul;99(PB):238–47. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0039128X15000380es_ES
dc.source.bibliographicCitationWang M, Zhang XN. Docosahexaenoic acid protectsneuronal and vascular of retinal ganglion cells from retinal ischemia and reperfusion injury inrats. Int J Clin Exp Med. 2016;9(4):7072–9.es_ES
dc.source.bibliographicCitationHong S-H, Khoutorova L, Bazan NG, Belayev L. Docosahexaenoic acid improves behavior and attenuates blood–brain barrier injury induced by focal cerebral ischemia in rats. Exp Transl Stroke Med [Internet]. 2015 Dec 28;7(1):3. Available from: http://www.etsmjournal.com/content/7/1/3es_ES
dc.source.bibliographicCitationKielar ML. Docosahexaenoic Acid Ameliorates Murine Ischemic Acute Renal Failure and Prevents Increases in mRNA Abundance for both TNF-and Inducible Nitric Oxide Synthase. J Am Soc Nephrol [Internet]. 2003 Feb 1;14(2):389–96. Available from: http://www.jasn.org/cgi/doi/10.1097/01.ASN.0000045047.44107.0Bes_ES
dc.source.bibliographicCitationSchunck W-H, Konkel A, Fischer R, Weylandt K-H. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacol Ther [Internet]. 2018 Mar;183:177–204. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163725817302668es_ES
dc.source.bibliographicCitationSanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res [Internet]. 2005 Jan;24(1):87–138. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1350946204000527es_ES
dc.source.bibliographicCitationFernández-Araque A, Giaquinta Aranda A, Laudo Pardo C, Rojo Aragüés A. Los antioxidantes en el proceso de patologías oculares. Nutr Hosp [Internet]. 2017 Mar 30;34(2):469. Available from: http://revista.nutricionhospitalaria.net/index.php/nh/article/view/420es_ES
dc.source.bibliographicCitationGoutham G, Manikandan R, Beulaja M, Thiagarajan R, Arulvasu C, Arumugam M, et al. A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance. Biomed Pharmacother [Internet]. 2017 Feb;86:232–41. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0753332216320509es_ES
dc.source.bibliographicCitationJarratt RA, Bartlett H, Eperjesi F. Retinal Effects of Resveratrol. US Ophthalmic Rev [Internet]. 2013;06(02):132. Available from: http://www.touchophthalmology.com/articles/retinal-effects-resveratroles_ES
dc.source.bibliographicCitationLevin LA, Albert DM. Ocular Disease [Internet]. Ocular Disease: Mechanisms and Management. Elsevier; 2010. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780702029837X00010es_ES
dc.source.bibliographicCitationBungau S, Abdel-Daim MM, Tit DM, Ghanem E, Sato S, Maruyama-Inoue M, et al. Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases. Oxid Med Cell Longev [Internet]. 2019 Feb 12;2019:1–22. Available from: https://www.hindawi.com/journals/omcl/2019/9783429/es_ES
dc.source.bibliographicCitationOak M-H, El Bedoui J, Schini-Kerth VB. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem [Internet]. 2005 Jan;16(1):1–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0955286304001792es_ES
dc.source.bibliographicCitationLim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet [Internet]. 2012 May;379(9827):1728–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22559899es_ES
dc.source.bibliographicCitationHennig R, Goepferich A. Nanoparticles for the treatment of ocular neovascularizations. Eur J Pharm Biopharm [Internet]. 2015 Sep;95(March):294–306. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0939641115001095es_ES
dc.source.bibliographicCitationCabrera MP, Chihuailaf RH. Antioxidants and the Integrity of Ocular Tissues. Vet Med Int [Internet]. 2011;2011:1–8. Available from: http://www.hindawi.com/journals/vmi/2011/905153/es_ES
dc.source.bibliographicCitationRahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging [Internet]. 2007;2(2):219–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18044138es_ES
dc.source.bibliographicCitationBosch-Morell F, Romá J, Marı́n N, Romero B, Rodriguez-Galietero A, Johnsen-Soriano S, et al. Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen. Free Radic Biol Med [Internet]. 2002 Sep;33(5):669–75. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0891584902009541es_ES
dc.source.bibliographicCitationMiranda M, Muriach M, Johnsen S, Bosch-Morell F, Araiz J, Romá J, et al. Estrés oxidativo en un modelo de retinopatía diabética experimental: tratamiento con antioxidantes. Arch Soc Esp Oftalmol [Internet]. 2004 Jun;79(6):289–94. Available from: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912004000600007&lng=en&nrm=iso&tlng=enes_ES
dc.source.bibliographicCitationGupta RC. Handbook of Toxicology of Chemical Warfare Agents [Internet]. Handbook of Toxicology of Chemical Warfare Agents: Second Edition. Elsevier; 2015. 1–1184 p. Available from: https://linkinghub.elsevier.com/retrieve/pii/C20130154025es_ES
dc.source.bibliographicCitationYar AS, Menevse S, Dogan I, Alp E, Ergin V, Cumaoglu A, et al. Investigation of Ocular Neovascularization–Related Genes and Oxidative Stress in Diabetic Rat Eye Tissues After Resveratrol Treatment. J Med Food [Internet]. 2012 Apr;15(4):391–8. Available from:http://www.liebertpub.com/doi/10.1089/jmf.2011.0135es_ES
dc.source.bibliographicCitationPintea A, Rugină D. Resveratrol and the Human Retina. In: Handbook of Nutrition, Diet, and the Eye [Internet]. Elsevier; 2019. p. 127–45. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128152454000089es_ES
dc.source.bibliographicCitationKim WT, Suh ES. Retinal Protective Effects of Resveratrol via Modulation of Nitric Oxide Synthase on Oxygen-induced Retinopathy. Korean J Ophthalmol [Internet]. 2010;24(2):108. Available from: https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2010.24.2.108es_ES
dc.source.bibliographicCitationKaneko H, Anzai T, Morisawa M, Kohno T, Nagai T, Anzai A, et al. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization. Atherosclerosis [Internet]. 2011 Aug;217(2):350–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0021915011003030es_ES
dc.source.bibliographicCitationTabrizi R, Tamtaji OR, Lankarani KB, Akbari M, Dadgostar E, Dabbaghmanesh MH, et al. The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr [Internet]. 2020 Feb 4;60(3):375–90. Available from: https://www.tandfonline.com/doi/full/10.1080/10408398.2018.1529654es_ES
dc.source.bibliographicCitationNagai N, Kubota S, Tsubota K, Ozawa Y. Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types. J Nutr Biochem [Internet]. 2014 Nov;25(11):1218–25. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0955286314001326es_ES
dc.source.bibliographicCitationRepossi G, Das UN, Eynard AR. Molecular Basis of the Beneficial Actions of Resveratrol. Arch Med Res [Internet]. 2020 Feb;17. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0188440919313293es_ES
dc.source.bibliographicCitationO’CONNOR BA, CARMAN J, ECKERT K, TUCKER G, GIVNEY R, CAMERON S. Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect [Internet]. 2007 Jan 19;135(1):34–9. Available from: https://www.cambridge.org/core/product/identifier/S095026880600656X/type/journal_articlees_ES
dc.source.bibliographicCitationTuo J, Ross RJ, Herzlich AA, Shen D, Ding X, Zhou M, et al. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol [Internet]. 2009 Aug;175(2):799–807. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002944010605913es_ES
dc.source.bibliographicCitationSouied EH, Aslam T, Garcia-Layana A, Holz FG, Leys A, Silva R, et al. Omega-3 Fatty Acids and Age-Related Macular Degeneration. Ophthalmic Res [Internet]. 2015 Nov 27;55(2):62–9. Available from: https://www.karger.com/Article/FullText/441359es_ES
dc.source.bibliographicCitationPark B, Corson TW. Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future. Front Pharmacol [Internet]. 2019 Feb 7;10:1–9. Available from: https://www.frontiersin.org/article/10.3389/fphar.2019.00095/fulles_ES
dc.source.bibliographicCitationUng L, Pattamatta U, Carnt N, Wilkinson-Berka JL, Liew G, White AJR. Oxidative stress and reactive oxygen species: A review of their role in ocular disease [Internet]. Vol. 131, Clinical Science. 2017. p. 2865–83. Available from: https://portlandpress.com/clinsci/article/131/24/2865/71822/Oxidative-stress-and-reactive-oxygen-species-aes_ES
dc.source.bibliographicCitationBazan NG. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci [Internet]. 2006 May;29(5):263–71. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0166223606000683es_ES
dc.source.bibliographicCitationGarcía Lozano I, López García S, Elosua de Juán I. Actualización en el manejo de la degeneración macular asociada a la edad. Rev Esp Geriatr Gerontol [Internet]. 2012 Sep;47(5):214–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0211139X12000091es_ES
dc.source.bibliographicCitationMares JA. Healthy Lifestyles Related to Subsequent Prevalence of Age- Related Macular Degeneration. Arch Ophthalmol [Internet]. 2011 Apr 11;129(4):470. Available from: http://archopht.jamanetwork.com/article.aspx?doi=10.1001/archophthalmol.2010.314es_ES
dc.source.bibliographicCitationPinazo-Durán MD, Zanón-Moreno V, Vinuesa-Silva I. Implicaciones de los ácidos grasos en la salud ocular. Arch Soc Esp Oftalmol [Internet]. 2008 Jul;83(7):401–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18592438es_ES
dc.source.bibliographicCitationSáenz Chávez PL, Garza Ocañas L, Badillo Castañeda CT, Tamez de la O EJ, Triana Verástegui J. Tolerabilidad del resveratrol y efectos sobre parámetros bioquímicos sanguíneos [Internet]. Vol. 45, Revista mexicana de ciencias farmacéuticas. scielomx; 2014. p. 1–7. Available from: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-01952014000400008es_ES
dc.source.bibliographicCitationMasís Borge A, Vega Solano M, Sánchez Valverde P. El Resveratrol Y Sus Posibles Usos Como Nueva. Rev Médica Costa Rica y Centroam [Internet]. 2013;(608):679–84. Available from: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2013/rmc134t.pdfes_ES
dc.source.bibliographicCitationCastellanos T L, Rodriguez D M. El efecto de omega 3 en la salud humana y consideraciones en la ingesta [Internet]. Vol. 42, Revista chilena de nutrición. scielocl; 2015. p. 90–5. Available from: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75182015000100012es_ES
dc.description.degreenameOptómetraes_ES
dc.description.degreelevelPregradoes_ES
dc.publisher.facultyFacultad de Optometríaes_ES
dc.description.notesPresenciales_ES
dc.type.documentEstudio de casoes_ES
dc.publisher.campusMedellín-
Aparece en las colecciones: Optometría

Ficheros en este ítem:
Fichero Tamaño  
2020_LauraMariaLondoñoDavid.pdf1.25 MBVisualizar/Abrir
2020_LauraMariaLondoñoDavid_Autorización.pdf
  Restricted Access
391.99 kBVisualizar/Abrir  Request a copy


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons